Denali Therapeutics Inc. — All Filings
751 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
10-Q/A
144
3
3/A
4
4/A
424B4
424B5
5
8-A12B
8-K
8-K/A
ARS
CERTNAS
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
S-1
S-1/A
S-3ASR
S-8
SC 13G
SC 13G/A
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 3 | 3 | 0000950170-25-082455 | Jun 5, 2025 | Jun 3, 2025 |
| 4 | 4 | 0000950170-25-082472 | Jun 5, 2025 | Jun 3, 2025 |
| 8-K | 8-K | 0001714899-25-000128 | Jun 3, 2025 | — |
| 8-K | 8-K | 0001714899-25-000104 | May 6, 2025 | — |
| 10-Q | 10-Q | 0001714899-25-000105 | May 6, 2025 | Mar 31, 2025 |
| ARS | ARS | 0001714899-25-000089 | Apr 17, 2025 | Dec 31, 2024 |
| DEFA14A | DEFA14A | 0001714899-25-000088 | Apr 17, 2025 | — |
| DEF 14A | DEF 14A | 0001714899-25-000087 | Apr 17, 2025 | Dec 31, 2024 |
| SCHEDULE 13G/A | — | 0001576419-25-000838 | Apr 17, 2025 | — |
| 8-K | 8-K | 0001714899-25-000077 | Apr 2, 2025 | — |
| 8-K | 8-K | 0001714899-25-000072 | Mar 5, 2025 | — |
| 8-K | 8-K | 0001714899-25-000067 | Feb 27, 2025 | — |
| S-8 | S-8 | 0001714899-25-000068 | Feb 27, 2025 | — |
| S-3ASR | S-3ASR | 0001628280-25-008647 | Feb 27, 2025 | — |
| 10-K | 10-K | 0001714899-25-000066 | Feb 27, 2025 | Dec 31, 2024 |
| SCHEDULE 13G/A | — | 0001422848-25-000029 | Feb 13, 2025 | — |
| SCHEDULE 13G/A | — | 0001088875-25-000027 | Feb 12, 2025 | — |
| 8-K | 8-K | 0001714899-25-000054 | Jan 13, 2025 | — |
| 4 | FORM 4 | 0001714899-25-000048 | Jan 8, 2025 | Jan 7, 2025 |
| 4 | FORM 4 | 0001714899-25-000050 | Jan 8, 2025 | Jan 6, 2025 |
| 4 | FORM 4 | 0001714899-25-000051 | Jan 8, 2025 | Jan 6, 2025 |
| 4 | FORM 4 | 0001714899-25-000049 | Jan 8, 2025 | Jan 6, 2025 |
| 144 | — | 0001714899-25-000047 | Jan 7, 2025 | — |
| 4 | FORM 4 | 0001714899-25-000027 | Jan 7, 2025 | Jan 3, 2025 |
| 8-K | 8-K | 0001714899-25-000007 | Jan 7, 2025 | Jan 6, 2025 |
| 4 | FORM 4 | 0001714899-25-000026 | Jan 7, 2025 | Jan 3, 2025 |
| 4 | FORM 4 | 0001714899-25-000028 | Jan 7, 2025 | Jan 3, 2025 |
| 144 | — | 0001714899-25-000035 | Jan 7, 2025 | — |
| 144 | — | 0001714899-25-000037 | Jan 7, 2025 | — |
| 144 | — | 0001714899-25-000039 | Jan 7, 2025 | — |
| 144 | — | 0001714899-25-000041 | Jan 7, 2025 | — |
| 144 | — | 0001714899-25-000043 | Jan 7, 2025 | — |
| 144 | — | 0001714899-25-000045 | Jan 7, 2025 | — |
| 4 | FORM 4 | 0001714899-25-000001 | Jan 3, 2025 | Jan 2, 2025 |
| 4 | FORM 4 | 0001714899-25-000002 | Jan 3, 2025 | Dec 31, 2024 |
| 144 | — | 0001950047-25-000045 | Jan 2, 2025 | — |
| 144 | — | 0001950047-24-010114 | Dec 31, 2024 | — |
| 4 | FORM 4 | 0001714899-24-000236 | Dec 31, 2024 | Dec 27, 2024 |
| 4 | FORM 4 | 0001714899-24-000235 | Nov 27, 2024 | Nov 25, 2024 |
| 4 | FORM 4 | 0001714899-24-000234 | Nov 26, 2024 | Nov 22, 2024 |
| 8-K | 8-K | 0001714899-24-000233 | Nov 18, 2024 | Nov 12, 2024 |
| 4 | FORM 4 | 0001714899-24-000219 | Nov 13, 2024 | Nov 11, 2024 |
| SC 13G/A | — | 0000315066-24-002715 | Nov 12, 2024 | — |
| 144 | — | 0001950047-24-008361 | Nov 12, 2024 | — |
| SC 13G | SEC SCHEDULE 13G | 0001422848-24-000355 | Nov 12, 2024 | — |
| 4 | FORM 4 | 0001714899-24-000217 | Nov 12, 2024 | Nov 7, 2024 |
| 4 | FORM 4 | 0001714899-24-000218 | Nov 12, 2024 | Nov 7, 2024 |
| SC 13G/A | SEC SCHEDULE 13G | 0000902219-24-000469 | Nov 8, 2024 | — |
| SC 13G/A | — | 0002012383-24-004043 | Nov 8, 2024 | — |
| 144 | — | 0001950047-24-008256 | Nov 7, 2024 | — |